Evidence map›Paper›PMID 34079635›Full record

ArticleAmerican journal of blood research2021

Association between pulmonary function and cardiac enzymes in sickle cell disease.

Charles Antwi-Boasiako, Michael M Asare, Ibrahim Baba, Alfred Doku, Kevin Adutwum-Ofosu, Charles Hayfron-Benjamin, Chamila P Asare, Robert Aryee, Gifty Boatemaah Dankwah, John Ahenkorah

Open access · greenAbstract read
In one paragraph

Article in American journal of blood research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Charles Antwi-BoasiakoDepartment of Physiology, University of Ghana Medical School, University of Ghana Accra, Ghana.
Michael M AsareDepartment of Physiology, University of Ghana Medical School, University of Ghana Accra, Ghana.
Ibrahim BabaDepartment of Physiology, University of Ghana Medical School, University of Ghana Accra, Ghana.
Alfred DokuDepartment of Medicine and Therapeutics, University of Ghana Medical School, University of Ghana Accra, Ghana.
Kevin Adutwum-OfosuDepartment of Anatomy, University of Ghana Medical School, University of Ghana Accra, Ghana.
Charles Hayfron-BenjaminDepartment of Physiology, University of Ghana Medical School, University of Ghana Accra, Ghana.
Chamila P AsareDepartment of Physiology, University of Ghana Medical School, University of Ghana Accra, Ghana.
Robert AryeeDepartment of Physiology, University of Ghana Medical School, University of Ghana Accra, Ghana.
Gifty Boatemaah DankwahDepartment of Physiology, University of Ghana Medical School, University of Ghana Accra, Ghana.
John AhenkorahDepartment of Anatomy, University of Ghana Medical School, University of Ghana Accra, Ghana.
University of Ghana · GH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThere is scarcity of data on association between lung function and cardiac markers in patients with sickle cell disease (SCD). Meanwhile, SCD affects multi-organs in any one population. There seem to be an association between reduced pulmonary function with cardiac dysfunction. The current study examined the association between pulomanry function with cardiac markers in patients with SCD. METHODOLOGY: This was a cross-sectional study with cases and controls. The cases (n=117) were made up of patients with SCD. The control subjects (n=58) were voluntary blood donors without SCD. The cellulose acetate electrophoresis was used to determine the genotypes of the study subjects. Blood samples were collected from all the study subjects for full blood count and measurement of cardiac enzymes. The cardiac enzymes measured were lactate dehydrogenase (LDH) and creatine kinase-myocardial band (CK-MB). Lung function test, using the vitalograph was done on all the study subjects. The Global Lung Initiative criteria were used to categorize lung disease as obstruction, restriction, mixed obstruction/restriction and normal.

resultsThe prevalence of elevated CK-MB and LDH among the SCD patients was 76.92% and 9.40% respectively, higher than the non-SCD controls (51.72% and 0% for elevated CK-MB and LDH respectively). Of all the impaired lung function, lung restriction was prevalent in all the study groups (30.77% and 15.52% for SCD patients and non-SCD controls respectively). In the fully adjusted model, reduced FEV1 was associated with nearly 3.5-fold higher odds of elevated CK-MB (odds ratio 3.35, 95% CI 1.26-8.90,

conclusionReduced FEV

Indexed as

cardiac enzymeslung functionmyocardial infarctionSickle cell disease

Identifiers

PMID34079635
PMCPMC8165713
OpenAlexW3165383488

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.